Burke Steven Keith - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 3, 2025, Burke Steven Keith's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Medical Officer), and currently has 809,090 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Burke Steven Keith - Insider Non-Derivative Transactions of AKBA Common Stock

Burke Steven Keith - Insider Non-Derivative Transactions at AKBA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 4, 2025	Sell -- (Common Stock)	7144	1.83	809090
Feb 4, 2025	Sell -- (Common Stock)	27236	2.1	816234
Feb 4, 2025	Sell -- (Common Stock)	23270	2.1	843470
Feb 1, 2025	Acquisition -- (Common Stock)	194900	0	866740
Mar 1, 2024	Sell -- (Common Stock)	7169	1.58	695840
Feb 28, 2024	Sell -- (Common Stock)	8367	1.52	703009
Feb 2, 2024	Sell -- (Common Stock)	24311	1.68	711376
Feb 1, 2024	Acquisition -- (Common Stock)	202200	0	735687
Aug 26, 2023	Sell -- (Common Stock)	27000	1.15	668840
May 17, 2023	Sell -- (Common Stock)	63567	1.07	530487
Mar 2, 2023	Sell -- (Common Stock)	1110	0.88	594054
Mar 2, 2023	Sell -- (Common Stock)	6400	0.88	595164
Mar 2, 2023	Sell -- (Common Stock)	6613	0.88	601564
Feb 28, 2023	Sell -- (Common Stock)	7539	0.81	608177
Feb 1, 2023	Acquisition -- (Common Stock)	196200	0	615716